Compare Medpace Holdings Inc (MEDP) vs Match Group Inc (MTCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Match Group Inc — how do they compare? Medpace Holdings Inc trades at $607 (market cap $16.90B), while Match Group Inc trades at $37 (market cap $8.45B). The key difference: Medpace Holdings Inc is far larger — about 2× Match Group Inc's market cap, and Match Group Inc pays a 2.17% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | MTCH | |
|---|---|---|
Market Cap | $16.90B | $8.45B |
Sector | Technology | Media |
52-Week High | $620.59 | $41.24 |
52-Week Low | $393.42 | $28.90 |
Enterprise Value | $16.52B | $11.42B |
Dividend Yield | — | 2.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MTCH trades at $36.73, down 1.42% amid mixed technical signals and recent earnings volatility. The stock shows bearish momentum with key support at $35, while fundamentals reveal strong profitability with 74.8% gross margins and 20.17% net income margin. Recent Q2 2026 earnings missed revenue estimates despite Tinder engagement improvements, creating investor uncertainty about near-term growth.
MTCH presents a value opportunity with attractive P/E of 13.05 and analyst consensus target of $42.33 (15% upside), but faces execution risks in Tinder's turnaround and high debt load. The 53% buy rating reflects optimism for Hinge growth and margin expansion, though quarterly volatility requires careful monitoring of user trends and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →
